110 related articles for article (PubMed ID: 11734335)
1. Prevention of liver metastasis of human colon cancer by selective matrix metalloproteinase inhibitor MMI-166.
Oba K; Konno H; Tanaka T; Baba M; Kamiya K; Ohta M; Kaneko T; Shouji T; Igarashi A; Nakamura S
Cancer Lett; 2002 Jan; 175(1):45-51. PubMed ID: 11734335
[TBL] [Abstract][Full Text] [Related]
2. Effect of combination therapy with matrix metalloproteinase inhibitor MMI-166 and mitomycin C on the growth and liver metastasis of human colon cancer.
Ohta M; Konno H; Tanaka T; Baba M; Kamiya K; Oba K; Kaneko T; Syouji T; Igarashi A; Nakamura S
Jpn J Cancer Res; 2001 Jun; 92(6):688-95. PubMed ID: 11429059
[TBL] [Abstract][Full Text] [Related]
3. Augmented anti-metastatic efficacy of a selective matrix metalloproteinase inhibitor, MMI-166, in combination with CPT-11.
Maki H; Hojo K; Tanaka H; Sawada TY; Maekawa R; Yoshioka T
Clin Exp Metastasis; 2002; 19(6):519-26. PubMed ID: 12405289
[TBL] [Abstract][Full Text] [Related]
4. Reduction of in vivo tumor growth by MMI-166, a selective matrix metalloproteinase inhibitor, through inhibition of tumor angiogenesis in squamous cell carcinoma cell lines of head and neck.
Katori H; Baba Y; Imagawa Y; Nishimura G; Kagesato Y; Takagi E; Ishii A; Yanoma S; Maekawa R; Yoshioka T; Nagashima Y; Kato Y; Tsukuda M
Cancer Lett; 2002 Apr; 178(2):151-9. PubMed ID: 11867199
[TBL] [Abstract][Full Text] [Related]
5. Anti-metastatic efficacy and safety of MMI-166, a selective matrix metalloproteinase inhibitor.
Maekawa R; Maki H; Wada T; Yoshida H; Nishida-Nishimoto K; Okamoto H; Matsumoto Y; Tsuzuki H; Yoshioka T
Clin Exp Metastasis; 2000; 18(1):61-6. PubMed ID: 11206840
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effect of a new selective matrix metalloproteinase inhibitor, MMI-166, on experimental pancreatic cancer.
Matsushita A; Onda M; Uchida E; Maekawa R; Yoshioka T
Int J Cancer; 2001 May; 92(3):434-40. PubMed ID: 11291083
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase inhibitor MMI-166 inhibits lymphogenous metastasis in an orthotopically implanted model of lung cancer.
Fujino H; Kondo K; Ishikura H; Maki H; Kinoshita H; Miyoshi T; Takahashi Y; Sawada N; Takizawa H; Nagao T; Sakiyama S; Monden Y
Mol Cancer Ther; 2005 Sep; 4(9):1409-16. PubMed ID: 16170033
[TBL] [Abstract][Full Text] [Related]
8. Anti-invasive and antiangiogenic effects of MMI-166 on malignant glioma cells.
Nakabayashi H; Yawata T; Shimizu K
BMC Cancer; 2010 Jun; 10():339. PubMed ID: 20587068
[TBL] [Abstract][Full Text] [Related]
9. Anti-invasive effect of MMI-166, a new selective matrix metalloproteinase inhibitor, in cervical carcinoma cell lines.
Iwasaki M; Nishikawa A; Fujimoto T; Akutagawa N; Manase K; Endo T; Yoshida K; Maekawa R; Yoshioka T; Kudo R
Gynecol Oncol; 2002 Apr; 85(1):103-7. PubMed ID: 11925127
[TBL] [Abstract][Full Text] [Related]
10. MMI-166, a selective matrix metalloproteinase inhibitor, promotes apoptosis in human pancreatic cancer.
Gao CC; Gong BG; Wu JB; Cheng PG; Xu HY; Song DK; Li F
Med Oncol; 2015 Jan; 32(1):418. PubMed ID: 25471789
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of liver metastasis from orthotopically implanted colon cancer in nude mice by transfection of the TIMP-1 gene into KM12SM cells.
Yamauchi K; Ogata Y; Nagase H; Shirouzu K
Surg Today; 2001; 31(9):791-8. PubMed ID: 11686557
[TBL] [Abstract][Full Text] [Related]
12. An ultra-metastatic model of human colon cancer in nude mice.
Sun FX; Sasson AR; Jiang P; An Z; Gamagami R; Li L; Moossa AR; Hoffman RM
Clin Exp Metastasis; 1999 Feb; 17(1):41-8. PubMed ID: 10390146
[TBL] [Abstract][Full Text] [Related]
13. Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas.
Matsuyama Y; Takao S; Aikou T
J Surg Oncol; 2002 Jun; 80(2):105-10. PubMed ID: 12173379
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of gelatinolytic activity in tumor tissues by synthetic matrix metalloproteinase inhibitor: application of film in situ zymography.
Ikeda M; Maekawa R; Tanaka H; Matsumoto M; Takeda Y; Tamura Y; Nemori R; Yoshioka T
Clin Cancer Res; 2000 Aug; 6(8):3290-6. PubMed ID: 10955815
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer.
Nagatsuka I; Yamada N; Shimizu S; Ohira M; Nishino H; Seki S; Hirakawa K
Int J Cancer; 2002 Aug; 100(5):515-9. PubMed ID: 12124799
[TBL] [Abstract][Full Text] [Related]
16. SERPINA3 Silencing Inhibits the Migration, Invasion, and Liver Metastasis of Colon Cancer Cells.
Cao LL; Pei XF; Qiao X; Yu J; Ye H; Xi CL; Wang PY; Gong ZL
Dig Dis Sci; 2018 Sep; 63(9):2309-2319. PubMed ID: 29855767
[TBL] [Abstract][Full Text] [Related]
17. Integrin alpha v beta 6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver.
Yang GY; Xu KS; Pan ZQ; Zhang ZY; Mi YT; Wang JS; Chen R; Niu J
Cancer Sci; 2008 May; 99(5):879-87. PubMed ID: 18294287
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
Wang L; Chen W; Xie X; He Y; Bai X
Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
[TBL] [Abstract][Full Text] [Related]
19. Augmented growth inhibition of B16-BL6 melanoma by combined treatment with a selective matrix metalloproteinase inhibitor, MMI-166, and cytotoxic agents.
Hojo K; Maki H; Sawada TY; Maekawa R; Yoshioka T
Anticancer Res; 2002; 22(6A):3253-9. PubMed ID: 12530072
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of MT1-MMP is insufficient to increase experimental liver metastasis of human colon cancer cells.
Yamamoto H; Noura S; Okami J; Uemura M; Takemasa I; Ikeda M; Ishii H; Sekimoto M; Matsuura N; Monden M; Mori M
Int J Mol Med; 2008 Dec; 22(6):757-61. PubMed ID: 19020773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
